Deciphera Pharmaceuticals (DCPH) Revenue & Revenue Breakdown
Deciphera Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$163.36M
Latest Revenue (Q)
$45.00M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Deciphera Pharmaceuticals Revenue by Period
Deciphera Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $163.36M | 21.87% |
| 2022-12-31 | $134.04M | 39.41% |
| 2021-12-31 | $96.15M | 128.45% |
| 2020-12-31 | $42.09M | 68.35% |
| 2019-12-31 | $25.00M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Deciphera Pharmaceuticals generated $163.36M in revenue during NA 2023, up 21.87% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Deciphera Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $45.00M | -6.82% |
| 2023-12-31 | $48.29M | 11.50% |
| 2023-09-30 | $43.31M | 13.08% |
| 2023-06-30 | $38.30M | 14.53% |
| 2023-03-31 | $33.45M | -7.98% |
| 2022-12-31 | $36.34M | 1.03% |
| 2022-09-30 | $35.97M | 10.71% |
| 2022-06-30 | $32.49M | 11.19% |
| 2022-03-31 | $29.22M | 20.76% |
| 2021-12-31 | $24.20M | 4.22% |
| 2021-09-30 | $23.22M | -1.50% |
| 2021-06-30 | $23.57M | -6.29% |
| 2021-03-31 | $25.16M | 29.10% |
| 2020-12-31 | $19.49M | 26.13% |
| 2020-09-30 | $15.45M | 117.90% |
| 2020-06-30 | $7.09M | 11335.48% |
| 2020-03-31 | $62.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | -100.00% |
| 2019-06-30 | $25.00M | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | - |
Deciphera Pharmaceuticals generated $45.00M in revenue during Q1 2024, up -6.82% compared to the previous quarter, and up 123.81% compared to the same period a year ago.
Deciphera Pharmaceuticals Revenue Breakdown
Deciphera Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Product | $159.07M | - | - | - | - |
| Collaboration Arrangement | $4.28M | $8.53M | $8.76M | $2.63M | - |
| License | - | - | - | - | $25.00M |
Deciphera Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (97.38%), and Collaboration Arrangement (2.62%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Arrangement | $12.00M | - | $12.00M | $984.00K | $223.00K | $3.46M | $3.66M | $997.00K | $414.00K | $502.00K | $1.54M | $1.52M | $5.19M | $14.00K | $200.00K | $100.00K | - | - |
| Product | $42.55M | $117.25M | $41.82M | $4.83M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $100.00K | $25.00M |
Deciphera Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (78.00%), and Collaboration Arrangement (22.00%).
Deciphera Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| GERMANY | $17.96M | $14.30M | - | - |
| UNITED STATES | $121.55M | $97.22M | $81.48M | $38.00M |
| Non-US | $19.57M | $28.29M | $5.91M | $1.50M |
Deciphera Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (76.41%), Non-US (12.30%), and GERMANY (11.29%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $31.84M | $35.34M | $32.66M | $28.92M | $24.62M | $25.59M | $24.48M | $23.73M | $23.41M | $21.48M | $19.98M | $20.73M | $19.29M | $18.50M | $14.70M |
| Non-US | $10.71M | - | $9.16M | $8.40M | $8.60M | $7.29M | $7.84M | $7.76M | $5.40M | $2.21M | $1.71M | $1.32M | $675.00K | $1.00M | $500.00K |
Deciphera Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (74.82%), and Non-US (25.18%).
Deciphera Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NBIX | Neurocrine Biosciences | $1.89B | $590.20M |
| ALKS | Alkermes | $1.66B | $399.13M |
| PBH | Prestige Consumer Healthcare | $1.13B | $267.14M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| EVO | Evotec SE | $781.43M | $208.73M |
| SUPN | Supernus Pharmaceuticals | $607.52M | $168.32M |
| AMPH | Amphastar Pharmaceuticals | $593.24M | $182.39M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| IRWD | Ironwood Pharmaceuticals | $442.74M | $94.40M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
| AVDL | Avadel Pharmaceuticals | $27.96M | $41.50M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
DCPH Revenue FAQ
What is Deciphera Pharmaceuticals’s yearly revenue?
Deciphera Pharmaceuticals's yearly revenue for 2023 was $163.36M, representing an increase of 21.87% compared to 2022. The company's yearly revenue for 2022 was $134.04M, representing an increase of 39.41% compared to 2021. DCPH's yearly revenue for 2021 was $96.15M, representing an increase of 128.45% compared to 2020.
What is Deciphera Pharmaceuticals’s quarterly revenue?
Deciphera Pharmaceuticals's quarterly revenue for Q1 2024 was $45M, a -6.82% decrease from the previous quarter (Q4 2023), and a 34.55% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $48.29M, a 11.50% increase from the previous quarter (Q3 2023), and a 32.88% increase year-over-year (Q4 2022). DCPH's quarterly revenue for Q3 2023 was $43.31M, a 13.08% increase from the previous quarter (Q2 2023), and a 20.40% increase year-over-year (Q3 2022).
What is Deciphera Pharmaceuticals’s revenue growth rate?
Deciphera Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 69.90%, and for the last 5 years (2019-2023) was 553.42%.
What are Deciphera Pharmaceuticals’s revenue streams?
Deciphera Pharmaceuticals's revenue streams in c 23 are Product, and Collaboration Arrangement. Product generated $159.07M in revenue, accounting 97.38% of the company's total revenue Collaboration Arrangement generated $4.28M in revenue, accounting 2.62% of the company's total revenue, down -49.81% year-over-year.
What is Deciphera Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Deciphera Pharmaceuticals was Product. This segment made a revenue of $159.07M, representing 97.38% of the company's total revenue.